FDA revisiting breast implant safety after new concerns

U.S. medical authorities are revisiting the safety of breast implants used by millions of American women, the latest review in a multi-decade debate about their health effects.

An expert panel assembled by the Food and Drug Administration meets for two days starting Monday to discuss the latest evidence about the risks of illness and complications with the devices, which are used for cosmetic and reconstructive surgery.

MODEL HAD BREAST IMPLANTS REMOVED AFTER SHE SAYS BODY BEGAN REJECTING THEM

The FDA is grappling with a recently confirmed link between the implants and a rare form of cancer. Additionally, many women are pushing the agency to address longstanding — but unconfirmed — claims that implants can contribute to other chronic ailments.

PLASTIC SURGERY ON THE RISE: BREAST AUGMENTATION, LIPOSUCTION AMONG MOST POPULAR PROCEDURES, STUDY FINDS

The FDA panel will hear from researchers, plastic surgeons, patients and manufacturers.

CLICK HERE TO GET THE FOX NEWS APP

For now, the FDA isn’t proposing any new restrictions or warnings.